The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps in developing personalized microbiome-based therapies.
FREE Webinar
Wednesday, November 29, 2023
2:30-4:00 PM Eastern Time
With 100 times the number of genes contained in the human genome, and an array of different cell types and functions, one can argue that members of our microbiome constitute an additional human organ system. Research to date has implicated microbial activity in autoimmune disease, cancer, and the obesity epidemic. As a major source of variability across people, understanding and altering an individual’s microbiome is both a challenge and novel avenue for personalized medicine and nutrition. For a detailed look at the progress made toward understanding the host-microbiome interplay and the efforts undertaken to achieve a steady state of mutualism for a larger human health benefit, The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps in developing personalized microbiome-based therapies. Attendees will have the opportunity to interact with experts, ask questions, and seek advice on topics related to their research.
Topics to be covered:
Mechanisms by which human microbiota influence health and disease
How multidimensional data are being employed to develop personalized therapies
Meet the Speakers:
Eran Elinav, PhD
Professor, Department of Immunology
Weizmann Institute of Science, Israel
Eran Segal, PhD
Professor, Department of Mathematics and Computer Science
Weizmann Institute of Science, Israel
